María  Font

María Font

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
LCLucía Cordeu
Lucía Cordeu
ECElena Cubedo
Elena Cubedo
EBEVA BANDRES
EVA BANDRES
ARAmaia Rebollo
Amaia Rebollo
XSXabi Sáenz
Xabi Sáenz
JGJesús García-Foncillas
Jesús García-Foncillas

1 August 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Plano DanielPlano Daniel
Plano Daniel
YBYlenia Baquedano
Ylenia Baquedano
DMDavid Moreno-Mateos
David Moreno-Mateos
MFMaría Font
María Font
AJAntonio Jimenez-Ruiz
Antonio Jimenez-Ruiz
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin

1 May 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
MDMaría J. Domínguez
María J. Domínguez
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
MFMaría Font
María Font
JPJuan A. Palop
Juan A. Palop
SFSara San Francisco
Sara San Francisco
JGJose Maria Garcia-Mina
Jose Maria Garcia-Mina

1 February 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Enrique Domínguez-ÁlvarezEnrique Domínguez-Álvarez
Enrique Domínguez-Álvarez
Plano DanielPlano Daniel
Plano Daniel
MFMaría Font
María Font
ACAlfonso Calvo
Alfonso Calvo
CPCelia Prior
Celia Prior
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin

1 January 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EAEsther Moreno Amatria
Esther Moreno Amatria
Plano DanielPlano Daniel
Plano Daniel
ILIranzu Lamberto
Iranzu Lamberto
MFMaría Font
María Font
IEIgnacio Encío
Ignacio Encío
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin

1 October 2011 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
Plano DanielPlano Daniel
Plano Daniel
MFMaría Font
María Font
JPJ.A. Palop
J.A. Palop
The understanding of the essential role of selenium (Se) in human health has increased substantially in recent decades. Micronutrient deficiencies are very common in the general population and may be even more common in patients with different pathologies due to genetic or environmental causes and prescription drug use. Selenium is used by people in the prevention and/or treatment of different disorders including cardiovascular disease, osteoarthritis, rheumatoid arthritis, hypothyroidism, stroke, atherosclerosis, cancer susceptibility and treatment, HIV, AIDS, neuronal diseases such as Alzheimer or amyotrophic lateral sclerosis, pancreatitis, depression, and diabetes amongst others. Several mechanisms have been suggested to mediate the biological effects of Se and these include antioxidant defence systems, synthesis and stability of metabolites that act as intermediates implicated in diverse selenoproteins expression pathways oxidative metabolism, immune system modulation, DNA intercalators, kinase regulation, enzymatic cofactor, and gene expression. A number of clinical trials in recent years have provided convincing evidence of the central role of this element, either alone or in combination with other micronutrients or antioxidants, in the prevention and treatment of multiple diseases. Based on these studies this review focuses on the advances made so far in the study of mechanisms and applications of selenium compounds that could be suitable for chronic diseases.